Status:
UNKNOWN
Dual Time Point PET in Lymphoma
Lead Sponsor:
Odense University Hospital
Conditions:
Hodgkin's and Non-Hodgkin's Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the value of dual time point PET/CT in lymphoma. Since FDG uptake is linked to glucose metabolism, PET imaging is also used to detect suspected sites for infectious and ...
Eligibility Criteria
Inclusion
- Age\>18 years
- Planned for curative treatment
Exclusion
- Previously treatment with chemotherapy or irradiation
- Primary CNS lymphoma
- Recurrent lymphoma
- Transformation from indolent lymphoma
- Presence of diabetes mellitus, HIV, chronic inflammatory disease or infections
- Pregnancy or lactation
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01894945
Start Date
March 1 2012
End Date
July 1 2014
Last Update
July 10 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital, Department of hematology
Odense, Denmark, 5000
2
Roskilde Hospital
Roskilde, Denmark, 4000